Navigation Links
BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa
Date:7/6/2012

BOSTON, MAResearchers at Brigham and Women's Hospital (BWH) have discovered a new vaccine candidate for the bacterium Pseudomonas aeruginosa taking advantage of a new mechanism of immunity.

The study was published online in the American Journal of Respiratory and Critical Care Medicine on June 21, 2012.

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections, particularly in patients on respirators, where it can cause so-called ventilator-associated pneumonia, which carries a very high mortality rate. Pseudomonas also causes lung infections in people with cystic fibrosis, a genetic disorder that renders the lungs susceptible to bacterial infection.

Despite more than 40 years of vaccine research and development, there is no clinically available vaccine for this bacterium. Most prior vaccine efforts have focused on generating antibodies to Pseudomonas toxins or surface molecules, especially the sugar coating on the bug called the lipopolysaccharide O antigen. These approaches have not yielded a licensed vaccine for humans.

Gregory Priebe, MD, BWH Division of Infectious Diseases, Department of Medicine, and Boston Children's Hospital Division of Critical Care Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, along with researchers from Harvard Medical School, constructed a vaccine based on a new mechanism of immunity to Pseudomonas mediated by T helper 17 (Th17) cells. Th17 cells are a recently described type of helper T cells that secrete the cytokine IL-17 and enhance antibacterial mucosal defenses.

In the current studies, the investigators designed a screen for Th17-stimulating protein antigens expressed by a molecular library of DNA encoding Pseudomonas proteins. The screen discovered that the Pseudomonas protein PopB is a very effective stimulator of Th17 immunity, and immunization with purified PopB protected mice from lethal pneumonia in an antibody-independent fashion.

The researchers are currently taking their work a step further by constructing conjugate vaccines using PopB as a protein carrier with the hopes of improving the effectiveness of the vaccine. They hope that the PopB-based vaccine might one day be used to prevent Pseudomonas infections in hospitalized patients and in people with cystic fibrosis.


'/>"/>

Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-2208
Brigham and Women's Hospital
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... ProElectric Cartoon is a ... X. Pick and choose from a variety of electric styles including zap, sizzles, and ... can customize shadow, dof blur, three dimensional rotation, and much more. ProElectric Cartoon’s simplistic ...
(Date:5/2/2016)... ... , ... The Civilian Corps of the U.S. Army Medical Command (MEDCOM) recognizes ... its uniformed service members, the retired service members, their families and other eligible beneficiaries ... 12th National Nurses Week. It acknowledges the hard work and dedication of the millions ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... Book for the 2016 Main Residency Match® (“the Match”), the system through which ... States teaching institutions. A record-high 30,750 positions were placed in the 2016 Match, ...
(Date:5/2/2016)... ... , ... MedPro Waste Disposal, LLC (MedPro) is proud to announce that it ... back service for an all-inclusive rate. MedPro Disposal President, Dan Hansen, says, “We’re really ... of the clients in the country who are looking for an alternative to their ...
(Date:5/2/2016)... ... 02, 2016 , ... Visceral fat, also known as “deep ... liver and pancreas. If not properly addressed, visceral fat can lead to serious ... Medical Oncology and Palliative Care, warns against the dangers of visceral fat. “Just ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... , May 2, 2016 Leading Economies with Fastest ... 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, , ... BRICS nations , which comprises of Brazil , ... and South Africa , registered the fastest GDP growth ... in China , recession in Brazil ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
(Date:4/29/2016)... India , April 29, 2016 ... Pipeline Review, H1 2016" market research report that ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
Breaking Medicine Technology: